Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Danova

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Tumori|May 11, 2006
Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II studyAlberto Riccardi, Silvia Brugnatelli, Marco Danova, et al.
Anticancer Research|March 14, 2007
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cellsCamillo Porta, Lucia Bonomi, Beatrice Lillaz, et al.
Journal of Cancer Research and Clinical Oncology|March 16, 2012
Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancerMariangela Manzoni, Sara Mariucci, Sara Delfanti, et al.
The New Microbiologica|July 7, 2015
Neutrophil CD64 expression: a reliable diagnostic marker of infection in advanced cancer patients?Giuditta Comolli, Martina Torchio, Elisa Lenta, et al.
American Journal of Clinical Oncology|April 2, 2004
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II studyMario Airoldi, Luigi Cattel, Giorgio Cortesina, et al.
Oncology|July 15, 2005
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findingsMatteo Della Porta, Marco Danova, Gian Matteo Rigolin, et al.
IEEE Transactions on Nanobioscience|September 10, 2015
3D Silicon Microstructures: A New Tool for Evaluating Biological Aggressiveness of Tumor CellsGiuliano Mazzini, Francesca Carpignano, Salvatore Surdo, et al.
Oncology Reports|March 10, 2005
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patientsCamillo Porta, Ilaria Imarisio, Mara De Amici, et al.
Tumori|July 23, 2021
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinibElena Bolzacchini, Monica Giordano, Lorenza Bertù, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2017
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendationsMatti Aapro, Ralph Boccia, Robert Leonard, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Tumori|May 11, 2006
Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II studyAlberto Riccardi, Silvia Brugnatelli, Marco Danova, et al.
Anticancer Research|March 14, 2007
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cellsCamillo Porta, Lucia Bonomi, Beatrice Lillaz, et al.
Journal of Cancer Research and Clinical Oncology|March 16, 2012
Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancerMariangela Manzoni, Sara Mariucci, Sara Delfanti, et al.
The New Microbiologica|July 7, 2015
Neutrophil CD64 expression: a reliable diagnostic marker of infection in advanced cancer patients?Giuditta Comolli, Martina Torchio, Elisa Lenta, et al.
American Journal of Clinical Oncology|April 2, 2004
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II studyMario Airoldi, Luigi Cattel, Giorgio Cortesina, et al.
Oncology|July 15, 2005
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findingsMatteo Della Porta, Marco Danova, Gian Matteo Rigolin, et al.
IEEE Transactions on Nanobioscience|September 10, 2015
3D Silicon Microstructures: A New Tool for Evaluating Biological Aggressiveness of Tumor CellsGiuliano Mazzini, Francesca Carpignano, Salvatore Surdo, et al.
Oncology Reports|March 10, 2005
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patientsCamillo Porta, Ilaria Imarisio, Mara De Amici, et al.
Tumori|July 23, 2021
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinibElena Bolzacchini, Monica Giordano, Lorenza Bertù, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2017
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendationsMatti Aapro, Ralph Boccia, Robert Leonard, et al.
Pageof 8